$THC
TENET HEALTHCARE CORP Stock $thc

$thc Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000007031822000051 Filed on October 28, 2022

Income Statement

Concept	2022 Q4	2022 Q3
Revenue	$4.990B	$4.801B
YoY Change	2.76%	-1.9%
Cost Of Revenue	$860.0M	$817.0M
YoY Change	2.63%	-1.21%
Gross Profit	$4.130B	$3.984B
YoY Change	2.79%	-2.04%
Gross Profit Margin	82.77%	82.98%
Selling, General & Admin	$2.306B	$2.230B
YoY Change	5.39%	0.95%
% of Gross Profit	55.84%	55.97%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$213.0M	$209.0M
YoY Change	5.97%	0.0%
% of Gross Profit	5.16%	5.25%
Operating Expenses	$3.551B	$3.457B
YoY Change	3.89%	-0.35%
Operating Profit	$579.0M	$527.0M
YoY Change	-3.5%	-48.03%
Interest Expense	-$154.0M	-$171.0M
YoY Change	6.94%	-175.33%
% of Operating Profit	-26.6%	-32.45%
Other Income/Expense, Net	$4.000M	$6.000M
YoY Change	-300.0%	-14.29%
Pretax Income	$321.0M	$380.0M
YoY Change	-39.2%	-50.9%
Income Tax	$47.00M	$112.0M
% Of Pretax Income	14.64%	29.47%
Net Earnings	$102.0M	$131.0M
YoY Change	-59.04%	-77.34%
Net Earnings / Revenue	2.04%	2.73%
Basic Earnings Per Share		$1.21
Diluted Earnings Per Share	$0.96	$1.192M
COMMON SHARES
Basic Shares Outstanding	108.1M shares	107.9M shares
Diluted Shares Outstanding		109.9M shares

Balance Sheet

Concept	2022 Q4	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$858.0M	$1.208B
YoY Change	-63.71%	-47.29%
Cash & Equivalents	$858.0M	$1.208B
Short-Term Investments
Other Short-Term Assets	$1.775B	$1.566B
YoY Change	14.0%	4.75%
Inventory	$405.0M	$394.0M
Prepaid Expenses	$400.0M	$358.0M
Receivables	$2.943B	$2.826B
Other Receivables	$0.00	$4.000M
Total Short-Term Assets	$5.981B	$5.998B
YoY Change	-15.46%	-13.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.462B	$6.291B
YoY Change	0.54%	2.09%
Goodwill	$10.12B	$9.979B
YoY Change	9.31%	15.2%
Intangibles	$1.424B	$1.441B
YoY Change	-4.88%	-2.64%
Long-Term Investments	$1.599B	$3.312B
YoY Change	-11.46%	29.17%
Other Assets	$19.00M	$55.00M
YoY Change	-70.77%	-60.71%
Total Long-Term Assets	$21.18B	$21.08B
YoY Change	3.27%	10.89%
TOTAL ASSETS
Total Short-Term Assets	$5.981B	$5.998B
Total Long-Term Assets	$21.18B	$21.08B
Total Assets	$27.16B	$27.08B
YoY Change	-1.53%	4.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.504B	$1.240B
YoY Change	15.69%	12.73%
Accrued Expenses	$991.0M	$1.030B
YoY Change	-9.83%	-22.73%
Deferred Revenue	$110.0M	$111.0M
YoY Change	-88.53%	-90.89%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$145.0M	$131.0M
YoY Change	7.41%	4.8%
Total Short-Term Liabilities	$4.476B	$4.276B
YoY Change	-12.39%	-20.51%
LONG-TERM LIABILITIES
Long-Term Debt	$14.93B	$14.96B
YoY Change	-3.72%	6.8%
Other Long-Term Liabilities	$1.787B	$3.028B
YoY Change	24.18%	90.2%
Total Long-Term Liabilities	$1.787B	$17.99B
YoY Change	24.18%	1030.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.476B	$4.276B
Total Long-Term Liabilities	$1.787B	$17.99B
Total Liabilities	$22.55B	$25.84B
YoY Change	-3.32%	16.24%
SHAREHOLDERS EQUITY
Retained Earnings	-$803.0M	-$905.0M
YoY Change	-33.86%	-38.14%
Common Stock	$8.000M	$8.000M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.142B	$1.235B
YoY Change
Total Liabilities & Shareholders Equity	$27.16B	$27.08B
YoY Change	-1.53%	4.49%

Cashflow Statement

Concept	2022 Q4	2022 Q3
OPERATING ACTIVITIES
Net Income	$102.0M	$131.0M
YoY Change	-59.04%	-77.34%
Depreciation, Depletion And Amortization	$213.0M	$209.0M
YoY Change	5.97%	0.0%
Cash From Operating Activities	$421.0M	$315.0M
YoY Change	17.93%	-27.08%
INVESTING ACTIVITIES
Capital Expenditures	$290.0M	-$165.0M
YoY Change	-195.39%	-248.65%
Acquisitions
YoY Change
Other Investing Activities	-$16.00M	-$137.0M
YoY Change	-98.68%	-112.36%
Cash From Investing Activities	-$306.0M	-$302.0M
YoY Change	-79.82%	-130.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-465.0M	-156.0M
YoY Change	-137.77%	-88.28%
NET CHANGE
Cash From Operating Activities	421.0M	315.0M
Cash From Investing Activities	-306.0M	-302.0M
Cash From Financing Activities	-465.0M	-156.0M
Net Change In Cash	-350.0M	-143.0M
YoY Change	-586.11%	-245.92%
FREE CASH FLOW
Cash From Operating Activities	$421.0M	$315.0M
Capital Expenditures	$290.0M	-$165.0M
Free Cash Flow	$131.0M	$480.0M
YoY Change	-80.18%	49.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000070318
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1000000	usd
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-7293
	dei	Entity Registrant Name EntityRegistrantName	TENET HEALTHCARE CORP
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-2557091
	dei	Entity Address Address Line1 EntityAddressAddressLine1	14201 Dallas Parkway
	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75254
	dei	City Area Code CityAreaCode	469
	dei	Local Phone Number LocalPhoneNumber	893-2200
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	108123186	shares
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	6000000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1208000000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2364000000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2826000000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2770000000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	394000000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	384000000	usd
CY2022Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	4000000	usd
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1566000000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1557000000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	5998000000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	7075000000	usd
CY2022Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	3312000000	usd
CY2021Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	3254000000	usd
CY2022Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	55000000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	65000000	usd
CY2022Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	6295000000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	5960000000	usd
CY2022Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	6291000000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	6427000000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	9979000000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	9261000000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1422000000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1374000000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1441000000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1497000000	usd
CY2022Q3	us-gaap	Assets Assets	27076000000	usd
CY2021Q4	us-gaap	Assets Assets	27579000000	usd
CY2022Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	131000000	usd
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	135000000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1240000000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1300000000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	781000000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	896000000	usd
CY2022Q3	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	279000000	usd
CY2021Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	254000000	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	249000000	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	203000000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	111000000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	959000000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1485000000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1362000000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4276000000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5109000000	usd
CY2022Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	14962000000	usd
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	15511000000	usd
CY2022Q3	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	804000000	usd
CY2021Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	791000000	usd
CY2022Q3	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	400000000	usd
CY2021Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	421000000	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	235000000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	36000000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	14000000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	15000000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1810000000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1439000000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	22501000000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	23322000000	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	2068000000	usd
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	2203000000	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	262500000	shares
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	1235000000	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	262500000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	156276317	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	155520691	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	8000000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	8000000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4771000000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4877000000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-229000000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-233000000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-905000000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1214000000	usd
CY2022Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	48327503	shares
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	48331649	shares
CY2022Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2410000000	usd
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2410000000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1028000000	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	1272000000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	1026000000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2507000000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2054000000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27076000000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27579000000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4801000000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4894000000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14184000000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14629000000	usd
CY2022Q3	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	54000000	usd
CY2021Q3	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	3000000	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	154000000	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	53000000	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	51000000	usd
CY2021Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	45000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	151000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	141000000	usd
CY2022Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2230000000	usd
CY2021Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2209000000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6538000000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6690000000	usd
CY2022Q3	us-gaap	Supplies Expense SuppliesExpense	817000000	usd
CY2021Q3	us-gaap	Supplies Expense SuppliesExpense	827000000	usd
	us-gaap	Supplies Expense SuppliesExpense	2413000000	usd
	us-gaap	Supplies Expense SuppliesExpense	2490000000	usd
CY2022Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1018000000	usd
CY2021Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1051000000	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	2966000000	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	3177000000	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	209000000	usd
CY2021Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	209000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	628000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	654000000	usd
CY2022Q3	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	24000000	usd
CY2021Q3	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	15000000	usd
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	97000000	usd
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	55000000	usd
CY2022Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-12000000	usd
CY2021Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-29000000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-50000000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-64000000	usd
CY2022Q3	thc	Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities NetGainsLossesOnSaleConsolidationAndDeconsolidationOfFacilities	0	usd
CY2021Q3	thc	Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities NetGainsLossesOnSaleConsolidationAndDeconsolidationOfFacilities	412000000	usd
	thc	Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities NetGainsLossesOnSaleConsolidationAndDeconsolidationOfFacilities	0	usd
	thc	Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities NetGainsLossesOnSaleConsolidationAndDeconsolidationOfFacilities	427000000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	596000000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1014000000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1797000000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2120000000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	222000000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	227000000	usd
	us-gaap	Interest Expense InterestExpense	671000000	usd
	us-gaap	Interest Expense InterestExpense	702000000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6000000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16000000	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-20000000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-109000000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-74000000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	380000000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	774000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1023000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1360000000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	112000000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	197000000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	297000000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	303000000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	268000000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	577000000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	726000000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1057000000	usd
CY2022Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	0	usd
CY2021Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	1000000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	1000000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	0	usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	usd
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1000000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1000000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	268000000	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	578000000	usd
	us-gaap	Profit Loss ProfitLoss	727000000	usd
	us-gaap	Profit Loss ProfitLoss	1057000000	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	137000000	usd
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	129000000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	418000000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	392000000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	131000000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	449000000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	309000000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	665000000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	131000000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	448000000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	308000000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	665000000	usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	usd
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	1000000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	1000000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	131000000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	449000000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	309000000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	665000000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.21
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	4.18
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.86
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	6.23
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.21
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.87
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.23
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.16
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	4.12
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.81
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	6.13
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.16
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.82
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.13
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107923000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107050000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107732000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106727000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109888000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108761000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	112288000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108465000	shares
CY2022Q3	us-gaap	Profit Loss ProfitLoss	268000000	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	578000000	usd
	us-gaap	Profit Loss ProfitLoss	727000000	usd
	us-gaap	Profit Loss ProfitLoss	1057000000	usd
CY2022Q3	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	2000000	usd
CY2021Q3	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	2000000	usd
	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	7000000	usd
	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	8000000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1000000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	0	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-4000000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	0	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	2000000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	1000000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	3000000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	1000000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	3000000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	3000000	usd
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	6000000	usd
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	9000000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1000000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	2000000	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	2000000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2000000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3000000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4000000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	7000000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	270000000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	581000000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	731000000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1064000000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	137000000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	129000000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	418000000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	392000000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	133000000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	452000000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	313000000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	672000000	usd
	us-gaap	Profit Loss ProfitLoss	727000000	usd
	us-gaap	Profit Loss ProfitLoss	1057000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	628000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	654000000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	208000000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	183000000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	47000000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	43000000	usd
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	97000000	usd
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	55000000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-50000000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-64000000	usd
	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	0	usd
	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	427000000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-109000000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-74000000	usd
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-14000000	usd
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-10000000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	23000000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	25000000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	1000000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	0	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	115000000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	16000000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-12000000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	7000000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	39000000	usd
CY2022Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	24000000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	202000000	usd
	thc	Increase Decrease In Inventories And Other Assets Current IncreaseDecreaseInInventoriesAndOtherAssetsCurrent	-89000000	usd
	thc	Increase Decrease In Inventories And Other Assets Current IncreaseDecreaseInInventoriesAndOtherAssetsCurrent	111000000	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	59000000	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-67000000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-942000000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-149000000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-28000000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	8000000	usd
	thc	Payments For Restructuring And Litigation Costs PaymentsForRestructuringAndLitigationCosts	157000000	usd
	thc	Payments For Restructuring And Litigation Costs PaymentsForRestructuringAndLitigationCosts	116000000	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1000000	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1000000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	662000000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1211000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	472000000	usd
	us-gaap	Business Exit Costs1 BusinessExitCosts1	25000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	354000000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	224000000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	64000000	usd
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	209000000	usd
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	1235000000	usd
	thc	Proceeds From Sale Of Marketable Securities Long Term Investments And Other Assets ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets	61000000	usd
	thc	Proceeds From Sale Of Marketable Securities Long Term Investments And Other Assets ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets	18000000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	68000000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	23000000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	8000000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	10000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-502000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	802000000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	2786000000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	3183000000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	2020000000	usd
	us-gaap	Other Restructuring Costs OtherRestructuringCosts	19000000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1413000000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	24000000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	15000000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	432000000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	316000000	usd
	us-gaap	Proceeds From Sale Of Interest In Corporate Unit ProceedsFromSaleOfInterestInCorporateUnit	16000000	usd
	us-gaap	Proceeds From Sale Of Interest In Corporate Unit ProceedsFromSaleOfInterestInCorporateUnit	14000000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	61000000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	19000000	usd
	thc	Proceeds From Grants From Affiliates Net Of Recoupment ProceedsFromGrantsFromAffiliatesNetOfRecoupment	0	usd
	thc	Proceeds From Grants From Affiliates Net Of Recoupment ProceedsFromGrantsFromAffiliatesNetOfRecoupment	-8000000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-49000000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-53000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1316000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2167000000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1156000000	usd
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	55000000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-154000000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2364000000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2446000000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1208000000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2292000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	601000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	664000000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-148000000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-54000000	usd
	thc	Number Of Hospitals Operated NumberOfHospitalsOperated	61	hospital
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2022Q3	thc	Proceeds From Government Assistance Including Contributions From Affiliates ProceedsFromGovernmentAssistanceIncludingContributionsFromAffiliates	51000000	usd
CY2021Q3	thc	Proceeds From Government Assistance Including Contributions From Affiliates ProceedsFromGovernmentAssistanceIncludingContributionsFromAffiliates	2000000	usd
	thc	Proceeds From Government Assistance Including Contributions From Affiliates ProceedsFromGovernmentAssistanceIncludingContributionsFromAffiliates	155000000	usd
	thc	Proceeds From Government Assistance Including Contributions From Affiliates ProceedsFromGovernmentAssistanceIncludingContributionsFromAffiliates	38000000	usd
CY2022Q3	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	54000000	usd
CY2021Q3	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	3000000	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	154000000	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	53000000	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	5000000	usd
CY2022Q3	us-gaap	Deferred Revenue DeferredRevenue	5000000	usd
CY2022Q3	thc	Contract With Customer Liability Recoupment Of Advance Payments ContractWithCustomerLiabilityRecoupmentOfAdvancePayments	405000000	usd
CY2021Q3	thc	Contract With Customer Liability Recoupment Of Advance Payments ContractWithCustomerLiabilityRecoupmentOfAdvancePayments	174000000	usd
	thc	Contract With Customer Liability Recoupment Of Advance Payments ContractWithCustomerLiabilityRecoupmentOfAdvancePayments	880000000	usd
	thc	Contract With Customer Liability Recoupment Of Advance Payments ContractWithCustomerLiabilityRecoupmentOfAdvancePayments	326000000	usd
	thc	Finance Lease Right Of Use Assets Acquired FinanceLeaseRightOfUseAssetsAcquired	64000000	usd
	thc	Finance Lease Right Of Use Assets Acquired FinanceLeaseRightOfUseAssetsAcquired	81000000	usd
	thc	Operating Lease Right Of Use Assets Acquired OperatingLeaseRightOfUseAssetsAcquired	296000000	usd
	thc	Operating Lease Right Of Use Assets Acquired OperatingLeaseRightOfUseAssetsAcquired	121000000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1441000000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2160000000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1208000000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2364000000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	71000000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	95000000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2152000000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1422000000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	730000000	usd
CY2022Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	711000000	usd
CY2022Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	711000000	usd
CY2022Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2863000000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1422000000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1374000000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	786000000	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	711000000	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	711000000	usd
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2871000000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1374000000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1497000000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	730000000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	47000000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	127000000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	124000000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	102000000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	82000000	usd
CY2022Q3	thc	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	248000000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	132000000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	139000000	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	358000000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	252000000	usd
CY2022Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	198000000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	199000000	usd
CY2022Q3	thc	Receivables From Government Programs Other Current Asset ReceivablesFromGovernmentProgramsOtherCurrentAsset	434000000	usd
CY2021Q4	thc	Receivables From Government Programs Other Current Asset ReceivablesFromGovernmentProgramsOtherCurrentAsset	627000000	usd
CY2022Q3	thc	Guarantees Other Current Asset GuaranteesOtherCurrentAsset	138000000	usd
CY2021Q4	thc	Guarantees Other Current Asset GuaranteesOtherCurrentAsset	104000000	usd
CY2022Q3	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	356000000	usd
CY2021Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	321000000	usd
CY2022Q3	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	82000000	usd
CY2021Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	54000000	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1566000000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1557000000	usd
	thc	Percentage Investee Results Reflected PercentageInvesteeResultsReflected	1
	us-gaap	Restructuring Costs RestructuringCosts	48000000	usd
CY2021Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	23000000	usd
CY2022Q3	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	153000000	usd
CY2021Q3	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	206000000	usd
	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	451000000	usd
	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	581000000	usd
CY2022Q3	thc	Contract With Customer Asset Percentage To Be Reclassified To Receivable Within90 Days ContractWithCustomerAssetPercentageToBeReclassifiedToReceivableWithin90Days	0.91
CY2021Q3	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1000000	usd
CY2022Q3	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1000000	usd
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	3000000	usd
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	3000000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	97000000	usd
	us-gaap	Restructuring Costs RestructuringCosts	78000000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	9000000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	10000000	usd
	us-gaap	Other Restructuring Costs OtherRestructuringCosts	19000000	usd
CY2022Q3	thc	Finance Leases And Mortgage Notes FinanceLeasesAndMortgageNotes	448000000	usd
CY2021Q4	thc	Finance Leases And Mortgage Notes FinanceLeasesAndMortgageNotes	443000000	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	137000000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	151000000	usd
CY2022Q3	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	15093000000	usd
CY2021Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	15646000000	usd
CY2022Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	131000000	usd
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	135000000	usd
CY2022Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	14962000000	usd
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	15511000000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	47000000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	43000000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2054000000	usd
CY2022Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	186000000	usd
CY2022Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	71000000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	95000000	usd
CY2022Q1	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	-8000000	usd
CY2022Q1	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	-10000000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2056000000	usd
CY2022Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	96000000	usd
CY2022Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	38000000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2000000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	9000000	usd
CY2022Q2	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	-16000000	usd
CY2022Q2	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	23000000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2114000000	usd
CY2022Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	194000000	usd
CY2022Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	58000000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2000000	usd
CY2022Q3	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	242000000	usd
CY2022Q3	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	13000000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2507000000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	937000000	usd
CY2021Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	141000000	usd
CY2021Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	61000000	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1000000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	3000000	usd
CY2021Q1	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	-9000000	usd
CY2021Q1	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	12000000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1016000000	usd
CY2021Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	177000000	usd
CY2021Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	43000000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5000000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	4000000	usd
CY2021Q2	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	3000000	usd
CY2021Q2	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	15000000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1169000000	usd
CY2021Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	505000000	usd
CY2021Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	51000000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3000000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	4000000	usd
CY2021Q3	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	3000000	usd
CY2021Q3	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	10000000	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1635000000	usd
	thc	Cybersecurity Incident Pre Tax Effect CybersecurityIncidentPreTaxEffect	100000000	usd
	us-gaap	Insurance Recoveries InsuranceRecoveries	13000000	usd
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1000000	usd
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	35000000	usd
	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	102000000	usd
	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	7000000	usd
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	2068000000	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	2203000000	usd
	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	251000000	usd
	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	234000000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	380000000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	774000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1023000000.000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1360000000	usd
CY2022Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	0	usd
CY2021Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	28000000	usd
CY2022Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	80000000	usd
CY2021Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	163000000	usd
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	215000000	usd
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	286000000	usd
CY2022Q3	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	15000000	usd
CY2021Q3	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	29000000	usd
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	40000000	usd
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	56000000	usd
CY2022Q3	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	29000000	usd
CY2021Q3	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	26000000	usd
	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	86000000	usd
	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	79000000	usd
CY2022Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1000000	usd
CY2021Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1000000	usd
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-4000000	usd
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-4000000	usd
CY2022Q3	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	36000000	usd
CY2021Q3	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	usd
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	113000000	usd
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	usd
CY2022Q3	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	11000000	usd
CY2021Q3	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	4000000	usd
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	18000000	usd
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	9000000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	112000000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	197000000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	297000000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	303000000	usd
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	113000000	usd
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	usd
	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	1000000	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	35000000	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	33000000	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q3	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	0	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	131000000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107923000	shares
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.21
CY2022Q3	us-gaap	Dilutive Securities DilutiveSecurities	-4000000	usd
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1965000	shares
CY2022Q3	thc	Effect Of Dilutive Securities Per Share Amount EffectOfDilutiveSecuritiesPerShareAmount	-0.05
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	127000000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109888000	shares
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.16
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	448000000	usd
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107050000	shares
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	4.18
CY2021Q3	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2021Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1711000	shares
CY2021Q3	thc	Effect Of Dilutive Securities Per Share Amount EffectOfDilutiveSecuritiesPerShareAmount	-0.06
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	448000000	usd
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108761000	shares
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	4.12
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	308000000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107732000	shares
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.86
	us-gaap	Dilutive Securities DilutiveSecurities	8000000	usd
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	4556000	shares
	thc	Effect Of Dilutive Securities Per Share Amount EffectOfDilutiveSecuritiesPerShareAmount	-0.05
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	316000000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	112288000	shares
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.81
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	665000000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106727000	shares
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	6.23
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1738000	shares
	thc	Effect Of Dilutive Securities Per Share Amount EffectOfDilutiveSecuritiesPerShareAmount	-0.10
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	665000000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108465000	shares
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	6.13
CY2021Q4	us-gaap	Assets Assets	27579000000	usd
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	165000000	usd
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss	0	usd
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss	1000000	usd
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	15000000	usd
CY2022Q3	us-gaap	Assets Assets	27076000000	usd
CY2021Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	111000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	472000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	354000000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4801000000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4894000000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14184000000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14629000000	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	51000000	usd
CY2021Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	45000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	151000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	141000000	usd
CY2022Q3	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	841000000	usd
CY2021Q3	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	855000000	usd
	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	2572000000	usd
	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	2466000000	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	209000000	usd
CY2021Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	209000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	628000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	654000000	usd
CY2022Q3	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	841000000	usd
CY2021Q3	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	855000000	usd
	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	2572000000	usd
	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	2466000000	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	209000000	usd
CY2021Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	209000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	628000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	654000000	usd
CY2022Q3	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	24000000	usd
CY2021Q3	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	15000000	usd
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	97000000	usd
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	55000000	usd
CY2022Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-12000000	usd
CY2021Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-29000000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-50000000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-64000000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	222000000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	227000000	usd
	us-gaap	Interest Expense InterestExpense	671000000	usd
	us-gaap	Interest Expense InterestExpense	702000000	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-20000000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-109000000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-74000000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6000000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16000000	usd
CY2022Q3	thc	Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities NetGainsLossesOnSaleConsolidationAndDeconsolidationOfFacilities	0	usd
CY2021Q3	thc	Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities NetGainsLossesOnSaleConsolidationAndDeconsolidationOfFacilities	412000000	usd
	thc	Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities NetGainsLossesOnSaleConsolidationAndDeconsolidationOfFacilities	0	usd
	thc	Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities NetGainsLossesOnSaleConsolidationAndDeconsolidationOfFacilities	427000000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	380000000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	774000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1023000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1360000000	usd

Files In Submission

Name	View Source	Status
0000070318-22-000051-index-headers.html	Edgar Link	pending
0000070318-22-000051-index.html	Edgar Link	pending
0000070318-22-000051.txt	Edgar Link	pending
0000070318-22-000051-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
thc-20220930.htm	Edgar Link	pending
thc-20220930.xsd	Edgar Link	pending
thc-20220930ex10b.htm	Edgar Link	pending
thc-20220930ex31a.htm	Edgar Link	pending
thc-20220930ex31b.htm	Edgar Link	pending
thc-20220930ex32.htm	Edgar Link	pending
thc-20220930_cal.xml	Edgar Link	unprocessable
thc-20220930_def.xml	Edgar Link	unprocessable
thc-20220930_pre.xml	Edgar Link	unprocessable
thc-20220930_lab.xml	Edgar Link	unprocessable
thc-20220930_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$THC
TENET HEALTHCARE CORP Stock $thc

2022 Q4 Form 10-Q Financial Statement

#000007031822000051 Filed on October 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THC TENET HEALTHCARE CORP Stock $thc

2022 Q4 Form 10-Q Financial Statement

#000007031822000051 Filed on October 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THC
TENET HEALTHCARE CORP Stock $thc